The role of metformin as a treatment for neuropsychiatric illness

Seetal Dodd; Luba Sominsky; Dan Siskind; Chiara C. Bortolasci; André F. Carvalho; Michael Maes; Adam J. Walker; Ken Walder; Alison R. Yung; Lana J. Williams; Hannah Myles; Tayler Watson; Michael Berk

doi:10.1016/j.euroneuro.2022.09.002

Related publications

Article2018

P4787Investigating the molecular mechanisms of carfilzomib-induced cardiotoxicity and the emerging role of metformin as a prophylactic therapy

Georgios Kremastiotis, Panagiotis Efentakis, Aimilia Varela, Constantinos H. Davos, Eleni‐Dimitra Papanagnou, Ioannis P. Trougakos, Efstathios Kastritis, Zoi Kanaki, Efstathios K. Iliodromitis, Apostolos Klinakis, Meletios A Dimopoulos, Evangelos Terpos, Ioanna Andreadou

Editorial Material2019

Neuropsychiatric Disturbances and Diabetes Mellitus: The Role of Oxidative Stress

Maria Luca, M. Di Mauro, George Perry

Article2015

The role of comorbidities in duration of untreated illness for bipolar spectrum disorders

Andréa Murru, Diego Primavera, Maria da Penha Monteiro Oliva, Marta Meloni, Eduard Vieta, Bernardo Carpiniello

Article2022

Symptom Recognition as a Mediator in the Self-Care of Chronic Illness

Bárbara Riegel, Maddalena De Maria, Claudio Barbaranelli, Maria Matarese, Davide Ausili, Anna Strömberg, Ercole Vellone, Tiny Jaarsma

Article2019

Synergistic Effect of Carfilzomib and Metformin in Vascular Plasticity; The Emerging Role of Autophagy

Panagiotis Efentakis, Ioanna Andreadou, Panagiota Nikolaou, Claudius Witzler, Svenja Siemer, Eftathios Kastritis, Philip Wenzel, Meletios A Dimopoulos, Evangelos Terpos